FDA NDC Directory · JSON-LD · Markdown

Ibandronate Sodium

NDC 65862-237 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED

Labeler / ManufacturerAurobindo Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA204502
Dosage form / routeTABLET, FILM COATED · ORAL
Active ingredientsIBANDRONATE SODIUM (150 mg/1)
Marketing started20160311
Package count1

External sources

Source: openFDA. Public-domain (CC0).